Genemarkers Overview
- Year Founded
-
2007
- Status
-
Private
- Employees
-
18
- Latest Deal Type
-
2ndary - Private
- Investors
-
3
Genemarkers General Information
Description
Provider of gene expression and genotyping services intended to enhance the utilization of genomics to improve health outcomes. The company offers comprehensive genomics services that expedite the translation of basic research into pharmaceutical and consumer product development, enabling the healthcare sector to provide testing services that ensure the improvement of healthcare, pharmaceutical research, and consumer products.
Contact Information
Website
www.genemarkersllc.comCorporate Office
- 126 East South Street
- Kalamazoo, MI 49007
- United States
Corporate Office
- 126 East South Street
- Kalamazoo, MI 49007
- United States
Genemarkers Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Secondary Transaction - Private | Completed | Generating Revenue | ||||
| 4. Grant | 21-Apr-2020 | Completed | Generating Revenue | |||
| 3. Later Stage VC | 01-Jun-2018 | Completed | Generating Revenue | |||
| 2. Debt - General | 27-Nov-2012 | $250K | $250K | Completed | Generating Revenue | |
| 1. Accelerator/Incubator | Completed | Startup |
Genemarkers Comparisons
Industry
Financing
Details
Genemarkers Competitors (5)
One of Genemarkers’s 5 competitors is GeneOmbio, a Formerly VC-backed company based in Pune, India.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| GeneOmbio | Formerly VC-backed | Pune, India | ||||
| Eremid Genomic Services | Venture Capital-Backed | Kannapolis, NC | ||||
| Genome Explorations | Corporate Backed or Acquired | Houston, TX | ||||
| Novogene | Formerly PE-Backed | Beijing, China | ||||
| Syngene International | Formerly PE-Backed | Bangalore, India |
Genemarkers Patents
Genemarkers Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20220235419-A1 | Risk evaluation of genomic susceptibility to opioid addiction | Inactive | 04-Jun-2019 | ||
| WO-2020247490-A1 | Risk evaluation of genomic susceptibility to opioid addiction | Inactive | 04-Jun-2019 |
Genemarkers Signals
Genemarkers Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Michigan Economic Development | Government | |||
| Angel (individual) | Minority | |||
| Southwest Michigan Innovation Center | Accelerator/Incubator | Minority |
Genemarkers FAQs
-
When was Genemarkers founded?
Genemarkers was founded in 2007.
-
Where is Genemarkers headquartered?
Genemarkers is headquartered in Kalamazoo, MI.
-
What is the size of Genemarkers?
Genemarkers has 18 total employees.
-
What industry is Genemarkers in?
Genemarkers’s primary industry is Other Pharmaceuticals and Biotechnology.
-
Is Genemarkers a private or public company?
Genemarkers is a Private company.
-
What is Genemarkers’s current revenue?
The current revenue for Genemarkers is .
-
How much funding has Genemarkers raised over time?
Genemarkers has raised $250K.
-
Who are Genemarkers’s investors?
Michigan Economic Development, , and Southwest Michigan Innovation Center have invested in Genemarkers.
-
Who are Genemarkers’s competitors?
GeneOmbio, Eremid Genomic Services, Genome Explorations, Novogene, and Syngene International are competitors of Genemarkers.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process